Variant report
Variant | esv3454899 |
---|---|
Chromosome Location | chr20:15435347-15436804 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr20:15430826..15432876-chr20:15434681..15437679,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs527634682 | chr20:15435410-15435411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs556009744 | chr20:15435421-15435422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs371795283 | chr20:15435476-15435477 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs202162311 | chr20:15435480-15435481 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs547401390 | chr20:15435487-15435488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs558343396 | chr20:15435493-15435494 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs6079836 | chr20:15435564-15435565 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs537514453 | chr20:15435588-15435589 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs147195654 | chr20:15435600-15435601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs140459278 | chr20:15435609-15435610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs377748896 | chr20:15435618-15435619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs6079837 | chr20:15435619-15435620 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs76148252 | chr20:15435634-15435635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs202147473 | chr20:15435669-15435670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs149337207 | chr20:15435672-15435673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs542987659 | chr20:15435677-15435678 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs16995786 | chr20:15435708-15435709 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs564101810 | chr20:15435713-15435714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs575235265 | chr20:15435730-15435731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs535300036 | chr20:15435732-15435733 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs200163204 | chr20:15435733-15435734 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs6079838 | chr20:15435756-15435757 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs572391488 | chr20:15435774-15435775 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs534566348 | chr20:15435807-15435808 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs543288518 | chr20:15435818-15435819 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs144602297 | chr20:15435820-15435821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs529457121 | chr20:15435828-15435829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs77263923 | chr20:15435843-15435844 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs566089221 | chr20:15435876-15435877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs557773118 | chr20:15435921-15435922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs188019818 | chr20:15435980-15435981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs533620446 | chr20:15435995-15435996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs6074898 | chr20:15436002-15436003 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
34 | rs548087619 | chr20:15436068-15436069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs34206223 | chr20:15436105-15436106 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs148412112 | chr20:15436112-15436113 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs537634784 | chr20:15436164-15436165 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs374586223 | chr20:15436173-15436174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs192352667 | chr20:15436258-15436259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs535212197 | chr20:15436261-15436262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs6079839 | chr20:15436282-15436283 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs142499232 | chr20:15436317-15436318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs545660319 | chr20:15436350-15436351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs558020498 | chr20:15436391-15436392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs540116372 | chr20:15436405-15436406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs77879241 | chr20:15436419-15436420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs543602052 | chr20:15436420-15436421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs145931727 | chr20:15436429-15436430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs529366720 | chr20:15436430-15436431 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs541541034 | chr20:15436451-15436452 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 16397240 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Wilms tumour | 21544195 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 16272173 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 19627613 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Colorectal cancer | 21645411 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Glaucoma | 21310917 | CNVD |
Alagille syndrome | 22470819 | CNVD |
Lung cancer | 16773561 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Alagille syndrome | 17576883 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Kabuki syndrome | 21720541 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Neurocytoma | 17123091 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Cancer | 20164919 | CNVD |
Multiple sclerosis | 20663923 | CNVD |
Schizophrenia | 20663923 | CNVD |
brain infarct | 20663923 | CNVD |
Breast cancer | 22522925 | CNVD |
Cancer | 20164920 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:15434600-15435800 | Enhancers | Fetal Kidney | kidney |
2 | chr20:15435400-15437400 | Enhancers | Primary monocytes fromperipheralblood | blood |
3 | chr20:15435600-15437400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
4 | chr20:15436800-15437200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |